CRYOFOCUS-B (06922) releases its annual performance report, showing a net loss of 44.456 million yuan for the year, a 60% decrease compared to the previous year.

22:54 27/03/2026

Kangqiang Bioscience-B (06922) released its annual financial performance for the year ended December 31, 2025. The group's revenue reached 95.268 million Chinese yuan, a year-on-year increase of 78%; the group suffered a loss of 44.456 million yuan for the year, a narrowing of 60% compared to the previous year; the basic loss per share was 0.16 yuan.

CRYOFOCUS-B (06922) released its annual performance for the year ending on December 31, 2025. The group achieved a revenue of 95.268 million RMB during the period, an increase of 78% year-on-year. The group incurred a loss of 44.456 million RMB during the year, a narrowing of 60% compared to the previous year. The basic loss per share was 0.16 RMB.

Aluminum Corporation of China (02600): Zhang Ruizhong was elected as an executive director of the ninth board of directors.

NANHUA FUTURES (02691): Cong Lin appointed as Co-Secretary of the Company.

JINHAI MED TECH (02225) announced its annual performance, with a net loss of 17.08 million Singapore dollars attributable to shareholders, a decrease of 4.9% year-on-year.

Aluminum Corporation of China (02600): Zhang Ruizhong was elected as an executive director of the ninth board of directors.

NANHUA FUTURES (02691): Cong Lin appointed as Co-Secretary of the Company.

JINHAI MED TECH (02225) announced its annual performance, with a net loss of 17.08 million Singapore dollars attributable to shareholders, a decrease of 4.9% year-on-year.